Demographic Trends in Clear Cell Renal Cell Carcinoma: Insights from Tertiary Hospital in Surabaya
Clear cell renal cell carcinoma
DOI:
https://doi.org/10.59747/smjidisurabaya.v3i1.96Kata Kunci:
Clear cell renal cell carcinoma; kidney cancer, demographicAbstrak
Background: Clear cell renal cell carcinoma (ccRCC) is the most common renal malignancy, with distinct clinicopathological features. Despite established global patterns, regional characteristics in Indonesia remain understudied. This study describes ccRCC profiles at a tertiary Indonesian hospital, focusing on demographic trends, tumor characteristics, and staging patterns to enhance local diagnostic and management approaches. Objective: This study aims to describe the characteristics of ccRCC in Dr. Soetomo General Academic Hospital from 2014-2022. Material and Method: This is a retrospective descriptive study using secondary data including age, sex, tumor size, and pathological grade. Result: There were 50 patients of ccRCC throughout 9 years, most of them were male (70%), and 30% were female. Age group span between 31-80, with 51-60 age group being the most dominant (18%). Tumor sizes were grouped by <7 cm (40%) and >7 cm (60%), with 14 cm being the biggest size. The most common histopathology stage was T2 (42%), followed by T3 (32%), T1 (14%), and T4 (12%). Conclusion: The most common patients of ccRCC in Dr. Soetomo General Academic Hospital Surabaya were male patients, aged 51-60, with mostly > 7cm tumor size and in stage T2.
Referensi
Al Azab, R.S., Al-Zubi, M.T., Aladaileh, M.A.A., Darwazeh, H., Alshboul, M., Khader, Y.S., Ghalayini, I.F., Mustafa Ali, M.A., Al Demour, S., 2024. Renal cell carcinoma: an overview of the epidemiology, presentation, histopathological characteristics, and surgical treatment variation between old and new era – a cross-sectional study. Int. J. Surg. Open 62, 140–143.
American Joint Committe on Cancer, American College of Surgeons, 2018. AJCC Cnacer staging manual, 8th ed, Atlas of Cross-Sectional and Projective MR Cholangiopancreatography. Springer`, Chicago, US.
Amin, M.B., Greene, F.L., Edge, S.B., Compton, C.C., Gershenwald, J.E., Brookland, R.K., Meyer, L., Gress, D.M., Byrd, D.R., Winchester, D.P., 2017. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA. Cancer J. Clin. 67, 93–99.
Barrera-Juarez, E., Halun-Trevino, A.N., Ruelas-Martinez, M., Madero-Frech, A., Camacho-Trejo, V., Estrada-Bujanos, M., Bojorquez, D., Uribe-Montoya, J., Rodriguez-Covarrubias, F., Villarreal-Garza, C., 2024. Prognosis impact and clinical findings in renal cancer patients: comparative analysis between public and private health coverage in a cross-sectional and multicenter context. Cancer Causes Control 36, 265–273.
Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J.A., Kassouf, W., Mitchell, T., Montironi, R., O’Brien, T., Panebianco, V., Scelo, G., Shuch, B., van Poppel, H., Blosser, C.D., Psutka, S.P., 2022. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur. Urol. 82, 529–542.
Chen, L., Ma, X., Li, H., Gu, L., Li, X., Gao, Y., Xie, Y., Zhang, X., 2017. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy. PLoS One 12, 2–11.
Cirillo, L., Innocenti, S., Becherucci, F., 2024. Global epidemiology of kidney cancer. Nephrol. Dial. Transplant. 39, 920–928.
Danzig, M.R., Weinberg, A.C., Ghandour, R.A., Kotamarti, S., McKiernan, J.M., Badani, K.K., 2014. The association between socioeconomic status, renal cancer presentation, and survival in the United States: A survival, epidemiology, and end results analysis. Urology 84, 583–589.
Dumith, S.C., Garcia, L.M.T., Da Silva, K.S., Menezes, A.M.B., Hallal, P.C., 2012. Predictors and health consequences of screen-time change during adolescence - 1993 Pelotas (Brazil) birth cohort study. J. Adolesc. Heal. 51, S16–S21.
Fateh, S., Arkawazi, L., Tahir, S., Rashid, R., Rahman, D., Aghaways, I., Kakamad, F., Salih, A., Bapir, R., Fakhralddin, S., Fattah, F., Abdalla, B., Mohammed, S., 2023. Renal cell carcinoma T staging: Diagnostic accuracy of preoperative contrast‑enhanced computed tomography. Mol. Clin. Oncol. 18, 1–7.
Fiebig, J., Kraywinkel, K., 2019. Epidemiology of renal cell carcinoma in Germany. Onkologe 25, 483–487.
Gkolfinopoulos, S., Psyrri, A., Bamias, A., 2020. Clear-cell renal cell carcinoma - A comprehensive review of agents used in the contemporary management of advanced/metastatic disease. Oncol. Rev. 20.
Gopee-Ramanan, P., Chin, S., Lim, C., Shanbhogue, K.P., Schieda, N., Krishna, S., 2022. Renal Neoplasms in Young Adults. Radiographics 42, 433–450.
Gürsoy, D., Seçinti, İ.E., Hakverdi, S., Görür, S., 2020. Renal Cell Carcinoma : Epidemiological Profile and Histopathological Features. Bull Urooncol 19, 68–73.
Hellenthal, N.J., Bermejo, C.E., 2012. The role of socioeconomic status in renal cell carcinoma. Urol. Oncol. Semin. Orig. Investig. 30, 89–94.
Holipah, H., Sulistomo, H.W., Maharani, A., 2020. Tobacco smoking and risk of all-cause mortality in Indonesia. PLoS One 15, 1–12.
Hsieh, J.J., Purdue, M.P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D.Y., Larkin, J., Ficarra, V., 2017. Renal cell carcinoma. Nat. Rev. Dis. Prim. 3.
Kanwal, R., 2023. Metastasis in renal cell carcinoma: Biology and treatment. Adv. Cancer Biol. - Metastasis 7, 100094.
Kase, A.M., George, D.J., Ramalingam, S., 2023. Clear Cell Renal Cell Carcinoma: From Biology to Treatment. Cancers (Basel). 15, 1–15.
Klein, L.W., 2022. Pathophysiologic Mechanisms of Tobacco Smoke Producing Atherosclerosis. Curr. Cardiol. Rev. 18.
Kshatri, J.S., Satpathy, P., Sharma, S., Bhoi, T., Mishra, S.P., Sahoo, S.S., 2022. Health research in the state of Odisha, India: A decadal bibliometric analysis (2011‑2020). J. Fam. Med. Prim. Care 6, 169–170.
Lai, G.S., Li, J.R., Wang, S.S., Chen, C.S., Yang, C.K., Hung, S.C., Cheng, C.L., Ou, Y.C., Chiu, K.Y., 2022. Tumor Size Significantly Affects Prognosis in Pathological T3a Renal Cell Carcinoma. Anticancer Res. 42, 2185–2191.
Liao, Z., Cui, L., Pai, P., Lu, Y., Li, X., Wang, G., Huang, W., Wang, D., Shaikh, N., Peng, Zhangzhe, Peng, Zhuoming, He, H., Liao, Z., 2025. Incidence and survival patterns of clear cell renal cell carcinoma from 2000 to 2017, based on A SEER Database. J. Cancer 16, 1591–1597.
Makino, T., Kadomoto, S., Izumi, K., Mizokami, A., 2022. Epidemiology and Prevention of Renal Cell Carcinoma. Cancers (Basel). 14, 1–20.
Naghdibadi, M., Momeni, M., Yavari, P., Gholaminejad, A., Roointan, A., 2023. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. Kidney Blood Press. Res. 48, 135–150.
Ng, C.S., Wood, C.G., Silverman, P.M., Tannir, N.M., Tamboli, P., Sandler, C.M., 2008. Renal cell carcinoma: Diagnosis, staging, and surveillance. Am. J. Roentgenol. 191, 1220–1232.
Ning, K., Peng, Y., Jiang, Y., Li, Z., Luo, X., Lin, L., Deng, M., Wu, Y., Huang, T., Huang, Y., Xie, Y., Yang, X., Zhang, M., Xiong, L., Zou, X., Zhou, Z., Zhou, F., Dong, P., Yu, C., Zhang, Z., 2023. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8+ T-cells highly infiltrated in males. Biol. Sex Differ. 14, 1–16.
Peired, A.J., Campi, R., Angelotti, M.L., Antonelli, G., Conte, C., Lazzeri, E., Becherucci, F., Calistri, L., Serni, S., Romagnani, P., 2021. Sex and gender differences in kidney cancer: Clinical and experimental evidence. Cancers (Basel). 13, 1–22.
Rahaju, A.S., Rahniayu, A., Kusumastuti, E.H., Wiratama, P.A., Thaib, P.K.P., Takaria, M., 2024. Correlation between PD-L1 and Ki-67 Expression at various T-stage Clear Cell Renal Cell Carcinomas. Res. J. Pharm. Technol. 17, 109–114.
Rahmatika, N., Wirjopranoto, S., Azmi, Y.A., Putra, A.G.P., Soetanto, K.M., 2024. Outcome of delayed presentation in patients with giant renal cell carcinoma: A case report. Int. J. Surg. Case Rep. 125, 110541.
Rusdhy, F., Djatisoesanto, W., Erawati, D., Fauziah, D., 2019. Characteristics of Renal Cell Carcinoma Patients in RSUD Dr Soetomo Surabaya in 2014-2017 486 | Publisher : Humanistic Network for Science and Technology Health Notions , Volume 3 Number 12 ( December 2019 ) ISSN 2580-4936 487 | Publisher : Humanistic Net. Heal. Notions 3, 486–489.
Satyana, R.P.U., Uli, R.E., Magliano, D., Zomer, E., Liew, D., Ademi, Z., 2020. Assessing the impact of smoking on the health and productivity of the working-age Indonesian population using modelling. BMJ Open 10, 1–12.
Schiavoni, V., Campagna, R., Pozzi, V., Cecati, M., Milanese, G., Sartini, D., Salvolini, E., Galosi, A.B., Emanuelli, M., 2023. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies. Cancers (Basel). 15.
Suryana Putra, D., Suryanti, S., Sihombing, A.T., 2016. Characteristics of Renal Cell Carcinoma in Dr. Hasan Sadikin General Hospital Bandung, 2010–2014. Althea Med. J. 3, 644–648.
Thaib, P.K.P., Rahaju, A.S., 2022. Clinicopathological profile of clear cell renal cell carcinoma. Int. J. Heal. Med. Sci. 5, 91–100.
Vocke, C.D., Ricketts, C.J., Metwalli, A.R., Pinto, P.A., Gautam, R., Raffeld, M., Merino, M.J., Ball, M.W., Linehan, W.M., 2022. Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease. Urology 165, 170–177.
Wang, Yuxiong, Wang, Yuantao, Feng, M., Lian, X., Lei, Y., Zhou, H., 2020. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review. J. Int. Med. Res. 48.
Weaver, C., Bin Satter, K., Richardson, K.P., Tran, L.K.H., Tran, P.M.H., Purohit, S., 2022. Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma. Biomedicines 10.
Yang, G., Wang, Y., Lai, Z.W., Zhang, H., Zhang, Y., Song, F., 2024. Renin-angiotensin-system and clear cell renal carcinoma: research advances and future perspectives. J. Cancer Metastasis Treat. 10.
Zhang, S., Fang, T., He, Y., Feng, W., Yu, Z., Zheng, Y., Zhang, C., Hu, S., Liu, Z., Liu, J., Yu, J., Zhang, H., He, A., Gong, Y., He, Z., Yang, K., Xi, Z., Yu, W., Zhou, L., Yao, L., Yue, S., 2024. VHL mutation drives human clear cell renal cell carcinoma progression through PI3K/AKT-dependent cholesteryl ester accumulation. eBioMedicine 103, 105070.
Unduhan
Diterbitkan
Terbitan
Bagian
Kategori
Lisensi
Hak Cipta (c) 2025 Aditya Sita Sari, Anny Setijo Rahaju, Nila Kurniasari
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
